Title:
PGDS阻害剤としてのピリミジンアミド化合物
Document Type and Number:
Japanese Patent JP5452925
Kind Code:
B2
Abstract:
This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
Inventors:
Susan Sea Aldas
John Jiki Zean
Zinki Lou
Lian mar
Run Mu
Harry rundle manson
Jeffrey Stephen Sabor
Sukantini Tulai Ratnam
Christopher Lauren Van Dussen
John Jiki Zean
Zinki Lou
Lian mar
Run Mu
Harry rundle manson
Jeffrey Stephen Sabor
Sukantini Tulai Ratnam
Christopher Lauren Van Dussen
Application Number:
JP2008534664A
Publication Date:
March 26, 2014
Filing Date:
October 04, 2006
Export Citation:
Assignee:
Aventis Pharmaceuticals Incorporated
International Classes:
C07D401/04; A61K31/505; A61K31/506; A61K31/5377; A61K31/662; A61P11/00; A61P11/02; A61P11/06; A61P29/00; A61P37/08; C07D239/28; C07D403/12; C07D405/12; C07D417/12; C07F9/6512; C07D401/12; C07D401/14; C07D413/12; C07D413/14
Domestic Patent References:
| JP3112985A | ||||
| JP2002003370A |
Foreign References:
| WO2004072069A1 | ||||
| WO2005032493A1 | ||||
| US20050165028 |
Other References:
STN International,2-Phenylpyrimidine-5-carboxylic acid N-(3-trifluoromethylphenyl)amide,file REGISTRY [online],2005年2月15日掲載,[平成24年4月25日検索],CAS Registry No. 831240-98-3
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi